scholarly journals The 3M Concept: Biomedical Translational Imaging from Molecules to Mouse to Man

2021 ◽  
Vol 5 (3) ◽  
pp. 155-160
Author(s):  
Domokos Máthé ◽  
Bálint Kiss ◽  
Bernadett Pályi ◽  
Zoltán Kis ◽  
László Forgách ◽  
...  

Abstract Imaging keeps pervading biomedical sciences from the nanoscale to the bedside. Connecting the hierarchical levels of biomedicine with relevant imaging approaches, however, remains a challenge. Here we present a concept, called “3M”, which can deliver a question, formulated at the bedside, across the wide-ranging hierarchical organization of the living organism, from the molecular level, through the small-animal scale, to whole-body human functional imaging. We present an example of nanoparticle development pipeline extending from atomic force microscopy to pre-clinical whole body imaging methods to highlight the essential features of the 3M concept, which integrates multi-scale resolution and quantification into a single logical process. Using the nanoscale to human clinical whole body approach, we present the successful development, characterisation and application of Prussian Blue nanoparticles for a variety of imaging modalities, extending it to isotope payload quantification and shape-biodistribution relationships. The translation of an idea from the bedside to the molecular level and back requires a set of novel combinatorial imaging methodologies interconnected into a logical pipeline. The proposed integrative molecules-to-mouse-to-man (3M) approach offers a promising, clinically oriented toolkit that lends the prospect of obtaining an ever-increasing amount of correlated information from as small a voxel of the human body as possible.

2011 ◽  
Author(s):  
Jun Xia ◽  
Zijian Guo ◽  
Andres Aguirre ◽  
Quing Zhu ◽  
Lihong V. Wang

2006 ◽  
Vol 50 (10) ◽  
pp. 3260-3268 ◽  
Author(s):  
Qing Zhu ◽  
Yoko Oei ◽  
Dirk B. Mendel ◽  
Evelyn N. Garrett ◽  
Montesa B. Patawaran ◽  
...  

ABSTRACT The lack of a robust small-animal model for hepatitis C virus (HCV) has hindered the discovery and development of novel drug treatments for HCV infections. We developed a reproducible and easily accessible xenograft mouse efficacy model in which HCV RNA replication is accurately monitored in vivo by real-time, noninvasive whole-body imaging of gamma-irradiated SCID mice implanted with a mouse-adapted luciferase replicon-containing Huh-7 cell line (T7-11). The model was validated by demonstrating that both a small-molecule NS3/4A protease inhibitor (BILN 2061) and human alpha interferon (IFN-α) decreased HCV RNA replication and that treatment withdrawal resulted in a rebound in replication, which paralleled clinical outcomes in humans. We further showed that protease inhibitor and IFN-α combination therapy was more effective in reducing HCV RNA replication than treatment with each compound alone and supports testing in humans. This robust mouse efficacy model provides a powerful tool for rapid evaluation of potential anti-HCV compounds in vivo as part of aggressive drug discovery efforts.


2002 ◽  
Vol 156 (2) ◽  
pp. 309-312 ◽  
Author(s):  
Gultekin Gulsen ◽  
L.Tugan Muftuler ◽  
Orhan Nalcioglu

2012 ◽  
Author(s):  
Jun Xia ◽  
Muhammad Chatni ◽  
Konstantin Maslov ◽  
Zijian Guo ◽  
Mark Anastasio ◽  
...  

Author(s):  
Jun Xia ◽  
Muhammad Chatni ◽  
Konstantin Maslov ◽  
Zijian Guo ◽  
Rebecca Sohn ◽  
...  

2018 ◽  
Vol 31 (8) ◽  
pp. e3952 ◽  
Author(s):  
Mikhail Zubkov ◽  
Anna A. Hurshkainen ◽  
Ekaterina A. Brui ◽  
Stanislav B. Glybovski ◽  
Mikhail V. Gulyaev ◽  
...  

2012 ◽  
Vol 11 (4) ◽  
pp. 7290.2011.00057 ◽  
Author(s):  
Nayoun Won ◽  
Sanghwa Jeong ◽  
Kangwook Kim ◽  
Jungheon Kwag ◽  
Joonhyuck Park ◽  
...  

Potential advantages of quantum dot (QD) imaging in the second optical window (SOW) at 1,000 to 1,400 nm over the first optical window (FOW) at 700 to 900 nm have attracted much interest. QDs that emit at 800 nm (800QDs) and QDs that emit at 1,300 nm (1,300QDs) are used to investigate the imaging depths at the FOW and SOW. QD images in biologic tissues are processed binarized via global thresholding method, and the imaging depths are determined using the criteria of contrast to noise ratio and relative apparent size. Owing to the reduced scattering in the SOW, imaging depth in skin can be extended by approximately three times for 1,300QD/SOW over 800QD/FOW. In liver, excitation of 1,300QD/SOW can be shifted to longer wavelengths; thus, the imaging depth can be extended by 1.4 times. Effects of quantum yield (QY), concentration, incidence angle, polarization, and fluence rate F on imaging depth are comprehensively studied. Under F approved by the Food and Drug Administration, 1,300QDs with 50% QY can reach imaging depths of 29.7 mm in liver and 17.5 mm in skin. A time-gated excitation using 1,000 times higher F pulses can obtain the imaging depth of ≈ 5 cm. To validate our estimates, in vivo whole-body imaging experiments are performed using small-animal models.


2019 ◽  
Vol 14 (10) ◽  
pp. S800
Author(s):  
K. Suemori ◽  
M. Kataoka ◽  
D. Okutani ◽  
T. Fujita ◽  
I. Togami ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document